Multimodality treatment resulting in long-term survival in hepatocellular carcinoma

B. Gasztonyi, A. Pár, István Battyány, Géza Hegedüs, Tamás F. Molnár, László Horváth, G. Mózsik

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The early detection and complex therapy of the hepatocellular carcinoma (HCC) is one of the most seasonable questions of the gastroenterology-oncology, because of the increasing prevalence of the primary liver cancer. The course of the hepatocellular carcinoma is rapid, untreated patients rarely live over 5-6 months. Combination of different treatment modalities in HCC can offer the best chances for survival. If possible, a surgical resection should be the primary procedure, followed by adjuvant cytostatic treatment and chemoembolisation. The authors report three cases with HCC with extremely long survival. The long-term survival achieved by multimodality therapy, as presented in these cases, seems to justify aggressive therapeutical approaches in HCC. It has been concluded, that early detection and complex, aggressive multimodality treatment - even repeated liver resections and surgical elimination of duplex distant metastases - can result in long-term survival with a good quality of life.

Original languageEnglish
Pages (from-to)413-416
Number of pages4
JournalJournal of Physiology Paris
Volume95
Issue number1-6
DOIs
Publication statusPublished - 2001

Fingerprint

Hepatocellular Carcinoma
Survival
Therapeutics
Cytostatic Agents
Gastroenterology
Liver Neoplasms
Quality of Life
Neoplasm Metastasis
Liver

Keywords

  • HCC
  • Long-term survival
  • Multimodality treatment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology (medical)

Cite this

Multimodality treatment resulting in long-term survival in hepatocellular carcinoma. / Gasztonyi, B.; Pár, A.; Battyány, István; Hegedüs, Géza; Molnár, Tamás F.; Horváth, László; Mózsik, G.

In: Journal of Physiology Paris, Vol. 95, No. 1-6, 2001, p. 413-416.

Research output: Contribution to journalArticle

Gasztonyi, B. ; Pár, A. ; Battyány, István ; Hegedüs, Géza ; Molnár, Tamás F. ; Horváth, László ; Mózsik, G. / Multimodality treatment resulting in long-term survival in hepatocellular carcinoma. In: Journal of Physiology Paris. 2001 ; Vol. 95, No. 1-6. pp. 413-416.
@article{3e67e460ec12484e9b8ad6af065ef1b5,
title = "Multimodality treatment resulting in long-term survival in hepatocellular carcinoma",
abstract = "The early detection and complex therapy of the hepatocellular carcinoma (HCC) is one of the most seasonable questions of the gastroenterology-oncology, because of the increasing prevalence of the primary liver cancer. The course of the hepatocellular carcinoma is rapid, untreated patients rarely live over 5-6 months. Combination of different treatment modalities in HCC can offer the best chances for survival. If possible, a surgical resection should be the primary procedure, followed by adjuvant cytostatic treatment and chemoembolisation. The authors report three cases with HCC with extremely long survival. The long-term survival achieved by multimodality therapy, as presented in these cases, seems to justify aggressive therapeutical approaches in HCC. It has been concluded, that early detection and complex, aggressive multimodality treatment - even repeated liver resections and surgical elimination of duplex distant metastases - can result in long-term survival with a good quality of life.",
keywords = "HCC, Long-term survival, Multimodality treatment",
author = "B. Gasztonyi and A. P{\'a}r and Istv{\'a}n Batty{\'a}ny and G{\'e}za Heged{\"u}s and Moln{\'a}r, {Tam{\'a}s F.} and L{\'a}szl{\'o} Horv{\'a}th and G. M{\'o}zsik",
year = "2001",
doi = "10.1016/S0928-4257(01)00056-0",
language = "English",
volume = "95",
pages = "413--416",
journal = "Journal de Physiologie",
issn = "0928-4257",
publisher = "Elsevier Masson SAS",
number = "1-6",

}

TY - JOUR

T1 - Multimodality treatment resulting in long-term survival in hepatocellular carcinoma

AU - Gasztonyi, B.

AU - Pár, A.

AU - Battyány, István

AU - Hegedüs, Géza

AU - Molnár, Tamás F.

AU - Horváth, László

AU - Mózsik, G.

PY - 2001

Y1 - 2001

N2 - The early detection and complex therapy of the hepatocellular carcinoma (HCC) is one of the most seasonable questions of the gastroenterology-oncology, because of the increasing prevalence of the primary liver cancer. The course of the hepatocellular carcinoma is rapid, untreated patients rarely live over 5-6 months. Combination of different treatment modalities in HCC can offer the best chances for survival. If possible, a surgical resection should be the primary procedure, followed by adjuvant cytostatic treatment and chemoembolisation. The authors report three cases with HCC with extremely long survival. The long-term survival achieved by multimodality therapy, as presented in these cases, seems to justify aggressive therapeutical approaches in HCC. It has been concluded, that early detection and complex, aggressive multimodality treatment - even repeated liver resections and surgical elimination of duplex distant metastases - can result in long-term survival with a good quality of life.

AB - The early detection and complex therapy of the hepatocellular carcinoma (HCC) is one of the most seasonable questions of the gastroenterology-oncology, because of the increasing prevalence of the primary liver cancer. The course of the hepatocellular carcinoma is rapid, untreated patients rarely live over 5-6 months. Combination of different treatment modalities in HCC can offer the best chances for survival. If possible, a surgical resection should be the primary procedure, followed by adjuvant cytostatic treatment and chemoembolisation. The authors report three cases with HCC with extremely long survival. The long-term survival achieved by multimodality therapy, as presented in these cases, seems to justify aggressive therapeutical approaches in HCC. It has been concluded, that early detection and complex, aggressive multimodality treatment - even repeated liver resections and surgical elimination of duplex distant metastases - can result in long-term survival with a good quality of life.

KW - HCC

KW - Long-term survival

KW - Multimodality treatment

UR - http://www.scopus.com/inward/record.url?scp=0034750465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034750465&partnerID=8YFLogxK

U2 - 10.1016/S0928-4257(01)00056-0

DO - 10.1016/S0928-4257(01)00056-0

M3 - Article

C2 - 11595468

AN - SCOPUS:0034750465

VL - 95

SP - 413

EP - 416

JO - Journal de Physiologie

JF - Journal de Physiologie

SN - 0928-4257

IS - 1-6

ER -